Multi-treatment optimal response-adaptive designs for phase III clinical trials
From MaRDI portal
Publication:744587
DOI10.1016/j.jkss.2010.04.004zbMath1296.62155OpenAlexW1987072912MaRDI QIDQ744587
Atanu Biswas, Saumen Mandal, Rahul Bhattacharya
Publication date: 25 September 2014
Published in: Journal of the Korean Statistical Society (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jkss.2010.04.004
Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Sequential statistical design (62L05)
Related Items (5)
Multi-arm response-adaptive designs for circular responses ⋮ Group-sequential response-adaptive designs for multi-armed trials ⋮ Sequential monitoring of response-adaptive randomized clinical trials with sample size re-estimation ⋮ On optimal designs for clinical trials: an updated review ⋮ On recent advances in optimal allocation designs in clinical trials
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Implementing optimal allocation for sequential continuous responses with multiple treatments
- The generalized Polya's urn design for sequential medical trials
- Asymptotic inference with response-adaptive treatment allocation designs
- A play-the-winner-type urn design with reduced variability
- An adaptive allocation for continuous response using Wilcoxon-Mann-Whitney score
- Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials.
- Response-adaptive designs for continuous outcomes
- Adaptive designs for normal responses with prognostic factors
- Sequential Estimation of a Linear Function of Means of Three Normal Populations
- The Randomized Play-the-Winner Rule in Medical Trials
- A sequential design for maximizing the probability of a favourable response
- Optimality, Variability, Power
- Inference for a RPW-Type Clinical Trial with Repeated Monitoring for the Treatment of Rheumatoid Arthritis
- Optimal Response‐Adaptive Designs for Continuous Responses in Phase III Trials
- Optimal Response‐Adaptive Designs for Normal Responses
- Implementing Optimal Allocation in Sequential Binary Response Experiments
- Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes
- Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses
This page was built for publication: Multi-treatment optimal response-adaptive designs for phase III clinical trials